Tryp Therapeutics Inc
The TRYPF stock trades on Otc Markets
Tryp Therapeutics is leading psychedelic drug development beyond mental health. Tryp Therapeutics focuses on areas of unmet medical need where other treatments have fallen short. Our pharmaceutical focus on psilocybin has the potential to transform the treatment of chronic pain and other indications, and relieve the suffering of millions of patients. Addressing unmet needs with proven potential. Tryp Therapeutics is one of the first players to help realize this promise, leading the next wave of psychedelic drug development that extends beyond mental health.
Source: Tryp Therapeutics Inc - 20220924